151 related articles for article (PubMed ID: 3047500)
21. Management of seminomatous testicular cancer: a binational prospective population-based study from the Swedish norwegian testicular cancer study group.
Tandstad T; Smaaland R; Solberg A; Bremnes RM; Langberg CW; Laurell A; Stierner UK; Ståhl O; Cavallin-Ståhl EK; Klepp OH; Dahl O; Cohn-Cedermark G
J Clin Oncol; 2011 Feb; 29(6):719-25. PubMed ID: 21205748
[TBL] [Abstract][Full Text] [Related]
22. Post-orchiectomy radiotherapy for stages I and II testicular seminoma.
Dosmann MA; Zagars GK
Int J Radiat Oncol Biol Phys; 1993 Jun; 26(3):381-90. PubMed ID: 7685748
[TBL] [Abstract][Full Text] [Related]
23. [Testicular cancer].
Oldenburg J; Lehne G; Fosså SD
Tidsskr Nor Laegeforen; 2008 Feb; 128(4):457-60. PubMed ID: 18274581
[TBL] [Abstract][Full Text] [Related]
24. Management of testicular seminoma at Westmead Hospital from 1980 to 87.
Lindeman GJ; Tiver KW
Aust N Z J Surg; 1991 Mar; 61(3):211-6. PubMed ID: 2003839
[TBL] [Abstract][Full Text] [Related]
25. Testicular seminoma: analysis of treatment results and failures.
Lester SG; Morphis JG; Hornback NB
Int J Radiat Oncol Biol Phys; 1986 Mar; 12(3):353-8. PubMed ID: 3082808
[TBL] [Abstract][Full Text] [Related]
26. The risk of second cancer (SC) in patients treated for testicular seminoma.
Hellbardt A; Mirimanoff RO; Obradovic M; Mermillod B; Paunier JP
Int J Radiat Oncol Biol Phys; 1990 Jun; 18(6):1327-31. PubMed ID: 2115033
[TBL] [Abstract][Full Text] [Related]
27. Non-seminomatous testicular cancer clinical stage I: prediction of outcome by histopathological parameters. A multivariate analysis.
Fosså SD; Stenwig AE; Lien HH; Ous S; Kaalhus O
Oncology; 1989; 46(5):297-300. PubMed ID: 2779945
[TBL] [Abstract][Full Text] [Related]
28. [Treatment of subdiaphragmatic lymph node metastases of primary testicular seminoma (stage II)].
Gardani G; Lattuada A; Valvo F
Radiol Med; 1989; 77(1-2):104-14. PubMed ID: 2928559
[TBL] [Abstract][Full Text] [Related]
29. Late relapses (>2 years) in patients with stage I testicular germ cell tumors: predictive factors and survival.
Fedyanin M; Tryakin A; Kanagavel D; Bulanov A; Burova A; Figurin K; Fainshtein I; Sergeev U; Zakharova T; Garin A; Tjulandin S
Urol Oncol; 2013 May; 31(4):499-504. PubMed ID: 21803619
[TBL] [Abstract][Full Text] [Related]
30. [Radiotherapy of testicular seminoma: changes over the past 10 years].
Mirimanoff RO
Cancer Radiother; 2003 Nov; 7 Suppl 1():70s-77s. PubMed ID: 15124547
[TBL] [Abstract][Full Text] [Related]
31. Health-related quality of life in patients with testicular cancer: a comparative analysis according to therapeutic modalities.
Miyake H; Muramaki M; Eto H; Kamidono S; Hara I
Oncol Rep; 2004 Oct; 12(4):867-70. PubMed ID: 15375514
[TBL] [Abstract][Full Text] [Related]
32. Prognostic factors in unselected patients with nonseminomatous metastatic testicular cancer: a multicenter experience.
Aass N; Klepp O; Cavallin-Stahl E; Dahl O; Wicklund H; Unsgaard B; Baldetorp L; Ahlström S; Fosså SD
J Clin Oncol; 1991 May; 9(5):818-26. PubMed ID: 1707957
[TBL] [Abstract][Full Text] [Related]
33. Optimal drug therapy in the treatment of testicular cancer.
Priest ER; Vogelzang NJ
Drugs; 1991 Jul; 42(1):52-64. PubMed ID: 1718685
[TBL] [Abstract][Full Text] [Related]
34. [Results of 15 years of treatment of nonseminoma testicular cancer: 84% 5-year survival rate].
van Veelen LR; Steyerberg EW; Cleton FJ; Keizer HJ
Ned Tijdschr Geneeskd; 1999 Mar; 143(11):564-8. PubMed ID: 10321275
[TBL] [Abstract][Full Text] [Related]
35. Long-term morbidity and quality of life in testicular cancer patients.
Fosså SD; Aass N; Ous S; Waehre H
Scand J Urol Nephrol Suppl; 1991; 138():241-6. PubMed ID: 1785014
[TBL] [Abstract][Full Text] [Related]
36. Long-term somatic side-effects and morbidity in testicular cancer patients.
Aass N; Kaasa S; Lund E; Kaalhus O; Heier MS; Fosså SD
Br J Cancer; 1990 Jan; 61(1):151-5. PubMed ID: 2297486
[TBL] [Abstract][Full Text] [Related]
37. [Adjuvant treatment for stage I of testicular germ cell tumours].
Lakomý R; Poprach A; Nēmecek R; Vyskocil J; Ondrová B; Kocák I; Kocáková I; Rehák Z; Vyzula R
Klin Onkol; 2009; 22(1):22-6. PubMed ID: 19534436
[TBL] [Abstract][Full Text] [Related]
38. [Human placental alkaline phosphatase (hPLAP) is the most frequently elevated serum marker in testicular cancer].
Neumann A; Keller T; Jocham D; Doehn C
Aktuelle Urol; 2011 Sep; 42(5):311-5. PubMed ID: 21809268
[TBL] [Abstract][Full Text] [Related]
39. Prognosis of human chorionic gonadotropin-producing seminoma treated by postoperative radiotherapy.
Mirimanoff RO; Sinzig M; Krüger M; Miralbell R; Thöni A; Ries G; Bosset JF; Bernier J; Bolla M; Nguyen TD
Int J Radiat Oncol Biol Phys; 1993 Sep; 27(1):17-23. PubMed ID: 8365938
[TBL] [Abstract][Full Text] [Related]
40. [Testicular tumor in Mongolian men (report of 35 cases)].
Jiang YG; Chen JH; Jiang R; Hang G; Wang GH; Wang D; Li FC; Liu H; Shi CJ; Wu HJ; Yuan YG
Zhonghua Nan Ke Xue; 2006 May; 12(5):397-400. PubMed ID: 16755865
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
